A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes

Summary

The main purpose of this study is to investigate the safety and tolerability of the study drug LY3457263 in healthy participants and participants with type 2 diabetes. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. The study has two parts (part A and B). Each part will last up to 10 weeks and may include up to either 13 (part A) or 19 (part B) visits.

Timeline

Start

2020-11-25

Primary completion

2021-12-21

Completion

2021-12-21

Drugs

Indications